A novel, highly potent and orally available orexin 2 receptor-selective agonist, TAK-861, ameliorates narcolepsy-like symptoms in two mouse models of narcolepsy
Authors:
- K. MitsukawaKMK. Mitsukawa
- M. TeradaMTM. Terada
- H. KimuraHKH. Kimura
- 13 February 2024
- journal article
- abstracts
- Published by Elsevier in Sleep Medicine
- Vol. 115, S12